你即將離開本站

並前往https://diatribe.org/bmsaz-resubmits-sglt-2-inhibitor-dapagliflozin-fda

BMS/AZ resubmits SGLT-2 inhibitor Dapagliflozin to FDA

On July 25, Bristol-Myers Squibb (BMS) and AstraZeneca (AZ) announced the resubmission of Forxiga (dapagliflozin), their SGLT-2 inhibitor ...

確定！ 回上一頁

查詢 「AZ forxiga」的人也找了：

  1. Dapagliflozin
    2.
  2. forxiga副作用
    3.
  3. dapagliflozin仿單
    4.
  4. forxiga優點
    5.
  5. forxiga中文
    6.
  6. forxiga減肥
    7.
  7. forxiga價錢
    8.
  8. forxiga適應症
    9.